Dr. Sophia A Sterner, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 434 W Ascension Way Fl 6, Murray, UT 84123 Phone: 210-667-3171 |
Dr. Kelly Katula, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5505 S 900 E Ste 240, Murray, UT 84117 Phone: 801-783-5011 Fax: 801-746-3734 |
Allen Oblad Naylor, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5505 S 900 E Ste 240, Murray, UT 84117 Phone: 801-783-5011 Fax: 801-746-3734 |
Dr. Allan Warren Belcher, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5505 S 900 E Ste 240, Murray, UT 84117 Phone: 801-783-5011 Fax: 801-746-3438 |
Strater Anderson Brown, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5505 S 900 E Ste 240, Murray, UT 84117 Phone: 801-783-5011 |
Stein Ingebretsen, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5505 S 900 E Ste 240, Murray, UT 84117 Phone: 801-783-5011 Fax: 801-746-3734 |
Manuel Jimenez, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5505 S 900 E Ste 240, Murray, UT 84117 Phone: 801-783-5011 |
News Archive
Asahi Kasei Corporation, and ZOLL Medical Corporation today jointly announced that Asahi Kasei, Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion.
Eighty-five percent of children's learning is related to vision. Yet in the U.S., 80 percent of children have never had an eye exam or any vision screening before kindergarten, statistics say. When they do, the vision screenings they typically receive can detect only one or two conditions.
A new study finds that individuals who have low expression of the "Celebrex gene," 15-PGDH, are actually resistant to Celebrex treatment when used to prevent colon cancer.
One in four deaths in the United States each year are due to heart disease, according to the Centers for Disease Control and Prevention. It's the leading killer of both men and women, but the disease's genetic complexity makes it difficult to treat.
› Verified 5 days ago